Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression
Our findings illuminate the dynamic proteomic and molecular landscape of HD. Future studies should validate these candidates in larger, more diverse cohorts and explore their mechanistic roles in HD pathology and progression.
Authors
- Christiana C. Christodoulou (ORCID: https://orcid.org/0000-0002-6071-1715)
- Christiana A. Demetriou (ORCID: https://orcid.org/0000-0003-4002-2880)
- Eleni Zamba‐Papanicolaou (ORCID: https://orcid.org/0000-0001-7727-9714)
Institutions
- University of Nicosia (CY)
- Cyprus Institute of Neurology and Genetics (CY)
Publication Details
- Journal
- Cells
- Published
- 2025-08-04
- DOI
- https://doi.org/10.3390/cells14151195
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Huntington's Disease Network